top of page

Our
Platforms

MiniBinders: A novel approach to extracellular protein degradation

  • We have identified a novel modality that is well-suited for targeted protein degradation. 

  • We have identified and characterized E3 ligases expressed on cancer cells, opening up the door to new targets and indications.

DALL·E 2023-03-26 20.21.30 - a realistic rendering of proteins.png

CargoTek: Re-doseable AAV therapies

  • Demonstrated re-dosing of AAV in mice with CargoTek.

  • Entered into a strategic research collaboration with AAV company.

DALL·E 2023-03-26 20.29.30 - adenoviruses populating the cells like stars in the night sky

StressTek: rHSPB5 treatment for autoimmune disorders

  • Unconventional use of rHSPB5 as a therapeutic. 

  • Acquired rights to DC-TAB, previously in the clinic for MS, in 2020. 

  • Demonstrated POC studies in 2021-2022. 

DALL·E 2023-03-26 20.31.45 - a bunch of small heat shock protein in space reducing inflamm
bottom of page